e: info@vacvbtx.com
p: +44 (0)20 809 07585
menu
close
  • Home
  • About us
    • Our vision
    • Our team
  • Our science
    • Our science
    • Publications
  • Our pipeline
  • Our careers
  • News & events
    • News
    • Events
  • Contact us
e: info@vacvbtx.com
p: +44 (0)20 809 07585

Latestpublications

VacV scientists have published numerous papers in peer-reviewed journals.
6 Sep 2023
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
Publication : Journal for ImmunoTherapy of Cancer
Authors : Dr Renato Brito Baleeiro, Dr Peng Liu, Dr Louisa S Chard Dunmall, Dr Carmela Di Gioia, Dr Ai Nagano, Dr Lauren Cutmore , Dr Jun Wang, Prof. Claude Chelala, Dr Lydon Wainaina Nyambura, Prof. Peter Walden, Prof. Nicholas Lemoine and Prof. Yaohe Wang
view article +
21 Oct 2022
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
Publication : Europe PMC
Authors : Ferguson M, Chard Dunmall LS, Gangeswaren R, Marelli G, Tysome J, Burns E, Whitehead MA, Aksoy E, Alusi G, Hiley C, Ahmed, J, Vanhaesebroeck B, Lemoine NR and Wang Y. (2020)
view article +
5 Jun 2022
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition
Publication : Molecular Therapy Oncolytics
Authors : Sun Y, Zhang Z, Zhang C, Zhang N, Chu Y, Chard Dunmall LS, Lemoine NR and Wang Y (2022)
view article +
26 May 2022
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
Publication : Frontiers
Authors : Baleeiro RB, Chard Dunmall LS, Liu P, Lu S, Lone Y, Lemoine NR and Wang Y (2022).
view article +
7 Apr 2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy
Publication : Taylor & Francis Online
Authors : Baleeiro RB, Bouwens CJ, Liu P, Di Gioia C, Chard Dunmall LS, Nagano A, Gangeswaran R, Chelala C, Kocher HM, Lemoine NR and Wang Y (2022)
view article +
21 Oct 2021
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
Publication : BMJ Journals
Authors : Marelli G, Chard Dunmall LS, Yuan M, Di Gioia C, Miao J, Cheng Z, Zhang Z, Liu P, Lemoine NR and Wang Y (2021).
view article +
26 Apr 2021
Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers
Publication : Aging
Authors : Lan T, Xue X, Dunmall LC, Miao J, Wang Y
view article +
26 Mar 2021
A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
Publication : Molecular Therapy Oncolytics
Authors : Wang N, Wang J, Zhang Z, Cao H, Yan W, Chu Y, Chard Dunmall LS and Wang Y (2021)
view article +
1 Apr 2020
A new oncolytic Vaccinia virus augments anti-tumor immune responses to prevent tumor recurrence and metastasis after surgery
Publication : BMJ Journals
Authors : Lu S, Zhang Z, Du P, Chard LS, Yan W, El-Khouri M, Wang Z, Zhang Z, Chu Y, Gao D, Zhang Q, Zhang L, Nagano A, Wang J, Chelala C, Lui J, Chen J, Liu P, Dong Y, Wang S, Li X, Dong J, Lemoine NR, Pei D and Wang Y. (2019)
view article +
15 Jan 2020
A Virus-Infected Reprogrammed Somatic cell-derived Tumor cell (VIReST) vaccination regime can prevent initiation and progression of pancreatic cancer
Publication : AACR Journals
Authors : Lu S, Zhang Z, Du P, Chard LS, Yan W, El-Khouri M, Wang Z, Zhang Z, Chu Y, Gao D, Zhang Q, Zhang L, Nagano A, Wang J, Chelala C, Lui J, Chen J, Liu P, Dong Y, Wang S, Li X, Dong J, Lemoine NR, Pei D and Wang Y. (2019)
view article +
24 Jan 2018
Immune checkpoint inhibitors in cancer therapy
Publication : The Journal of Biomedical Research
Authors : Webb ES, Liu P, Baleeiro R, Lemoine NR, Yuan M, Wang YH
view article +
9 Nov 2017
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
Publication : Nature Communications
Authors : Wang P, Li X, Wang J, Gao D, Li Y, Li H, Chu Y, Zhang Z, Liu H, Jiang G, Cheng Z, Wang S, Dong J, Feng B, Chard LS, Lemoine NR and Wang Y. (2017)
view article +
load more +
e: info@vacvbtx.com
p: +44 (0)20 809 07585
  • About us
  • Our science
  • Publications
  • Our pipeline
  • Our careers
  • News
  • Events
  • Contact us
© 2022 VacV Biotheraputics (UK) Ltd. | Design and development by TIG
Privacy Policy